Acquisition by Allen Jim L. of 50000 shares of Biocardia at 3.0 subject to Rule 16b-3
BCDA Stock | USD 2.13 0.11 4.91% |
About 62% of Biocardia's investor base is looking to short. The analysis of the overall investor sentiment regarding Biocardia suggests that many traders are alarmed. The current market sentiment, together with Biocardia's historical and current headlines, can help investors time the market. In addition, many technical investors use Biocardia stock news signals to limit their universe of possible portfolio assets.
Biocardia |
Filed transaction by Biocardia Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Biocardia Fundamental Analysis
We analyze Biocardia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biocardia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biocardia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Biocardia is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Biocardia Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biocardia stock to make a market-neutral strategy. Peer analysis of Biocardia could also be used in its relative valuation, which is a method of valuing Biocardia by comparing valuation metrics with similar companies.
Peers
Biocardia Related Equities
ABVC | ABVC Biopharma | 3.77 | ||||
NGENF | NervGen Pharma | 0.95 | ||||
ADAG | Adagene | 0.51 | ||||
INDP | Indaptus Therapeutics | 2.06 | ||||
AVTE | Aerovate Therapeutics | 3.41 | ||||
ANTX | AN2 Therapeutics | 3.85 | ||||
RZLT | Rezolute | 5.95 | ||||
FBRX | Forte Biosciences | 8.54 | ||||
KTTA | Pasithea Therapeutics | 8.57 | ||||
ACRV | Acrivon Therapeutics, | 10.33 | ||||
ANEB | Anebulo Pharmaceuticals | 10.43 | ||||
MLYS | Mineralys Therapeutics, | 11.87 | ||||
PTIX | Protagenic Therapeutics | 12.73 | ||||
ERAS | Erasca | 13.82 |
Complementary Tools for Biocardia Stock analysis
When running Biocardia's price analysis, check to measure Biocardia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocardia is operating at the current time. Most of Biocardia's value examination focuses on studying past and present price action to predict the probability of Biocardia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocardia's price. Additionally, you may evaluate how the addition of Biocardia to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Transaction History View history of all your transactions and understand their impact on performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |